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Aim of work: To study the relation between serum 25-hydroxy vitamin D levels and parameters of
cardiac systolic and diastolic functions in patients with LV systolic heart failure.
Patients and methods: The study included 60 patients admitted to our hospital for management of
symptomatic heart failure with systolic dysfunction (ejection fraction <40%). Venous samples were
taken to measure serum 25-hydroxy vitamin D. Trans-thoracic echocardiography was done for all
patients and parameters of systolic and diastolic functions were taken.
Results: Compared to patients with vitamin DP20 ng/ml, patients with vitamin D level <20 ng/ml
had signiﬁcantly higher average e0, signiﬁcantly shorter isovolumetric relaxation time (IVRT), and
signiﬁcantly lower E/e0, which is suggestive of a better diastolic function. While, also compared to
patients with vitamin D P20 ng/ml, patients with vitamin D level <20 ng/ml had higher end
systolic volume (ESV) (p= 0.05), larger end systolic dimension (ESD) (p= 0.056), higher interven-
tricular septum (IVS) thickness (p< 0.001), higher posterior wall (PW) thickness (p< 0.001),
higher mean LV wall thickness (p< 0.001), and higher LV mass (p= 0.05).
Conclusion: Vitamin D exerts biphasic effect on cardiac function according to its serum levels.
Reduced vitamin D (<20 ng/ml) appears to be associated with worse systolic functions in terms
of end systolic volume and end systolic dimension. Higher vitamin D levels (P20 ng/ml), however,
seem to be linked to worse LV diastolic functions in terms of lower e0, higher E/e0 and longer IVRT.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of
Cardiology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Worldwide, the prevalence of vitamin D deﬁciency is as high as
almost 50% among the elderly. A recent meta-analysis show-
ing that vitamin D supplementation signiﬁcantly decreased
all-cause mortality raised the public health interest in vitamin
300 M.A. Abdel Rahman et al.D. Myocardium is an important target tissue for vitamin D-
mediated effects on a genomic and non-genomic level.
Cardiomyocytes express the vitamin D receptor, and studies
in rodents have shown that vitamin D protects against cardiac
hypertrophy and myocardial dysfunction.1
The association between vitamin D and cardiovascular-dis-
ease events is widely debated and analyzed in the literature. In
a cross-sectional study, Pilz et al. measured 2 5-hydroxy vita-
min D (25 (OH) vitamin D) levels in 3299 Caucasian patients
who were routinely referred for coronary angiography.2 They
found that vitamin D deﬁciency is associated with prevalent
myocardial dysfunction, heart failure, and sudden cardiac
death. Although the link between vitamin D deﬁciency and
cardiovascular disease may be, in part, mediated through ele-
vated PTH and calcium-phosphate metabolism, recent scienti-
ﬁc evidence showed that vitamin D has 3 major potential
protective mechanisms. First, experimental studies indicate
that 1.25-(OH) Vitamin D could directly suppress rennin gene
expression. Second, is the presence in the cardiac muscle cells
of vitamin D receptors, a calcitriol-dependent Ca2+ binding
protein and a calcitriol-mediated rapid activation of
voltage-dependent Ca2+ channels. Third, vitamin D deﬁ-
ciency triggers secondary hyperparathyroidism, which then
directly promotes cardiac hypertrophy (the direct PTH toxicity
hypothesis).3
2. Aim of the work
To study the relation between serum 25-hydroxy vitamin D
levels and echocardiographic parameters of cardiac systolic
and diastolic functions in patients with LV systolic heart
failure.
2.1. Methods
2.1.1. Study population
The study included 60 patients of all age groups and both
sexes, admitted to Ain-Shams University hospital for manage-
ment of LV systolic heart failure. The included patients were
>18 years old, had EF <40% and presented with New
York Heart Association (NYHA) 3 and 4. The following
patients were excluded from the study: Patients with previous
vitamin D supplementations, patients with conditions known
to cause Vit. D deﬁciency e.g., malignancies, chronic liver dis-
ease, bowel disease causing mal-absorption, patients with
hemodialysis, etc., and patients with poor echogenicity. The
study was accepted by the ethical committee of Ain Shams
University, faculty of medicine.
2.1.2. Procedures
After oral consents from the patients, they were subjected to
full history taking including: cause of heart failure, NYHA
class on presentation to hospital, risk factors, and current
medication. Venous blood sampling was taken and sent for
laboratory quantitative measurements of serum levels of 25
(OH) vit. D (by using ELISA technique) and BNP. The
low vitamin D level (with more link to cardiovascular dis-
eases) is considered <20 ng/ml as reported by the National
Health and Nutritional Examination Surveys (NHANES)
(1988–1994, 2000–2004).4,5 Trans-thoracic echocardiographic
study was performed for all patients with commerciallyavailable echocardiography systems equipped with a 2.5-
MHz multifrequency phased array transducer (Vivid 5 or
Vivid 7, GE-Vingmed, Morton, Norway). Digital routine
gray scale 2-dimensional and tissue Doppler cine loops from
3 consecutive beats were obtained at end-expiratory apnea
from standard apical views at depths of 12–20 cm. Gain set-
tings were adjusted for routine gray scale 2D imaging to opti-
mize endocardial deﬁnitions. Routine digital gray scale 2-D
and tissue Doppler cine loops were obtained, including
mid-LV short axis views at the level of the papillary muscle
and standard apical views (4-chamber, 2-chamber, and
long-axis). Sector width was optimized to allow for complete
myocardial visualization while maximizing the frame rate. LV
end-diastolic volume, end-systolic volume (ESV), and ejection
fraction were obtained with the modiﬁed biplane Simpson’s
method from the apical 2- and 4-chamber images using the
biplane Simpson’s technique. Left atrial volume was calcu-
lated using the prolate ellipse method. All measurements were
made in >3 consecutive cardiac cycles and in >5 cycles if
the patient’s rhythm was AF and average values were used
for the ﬁnal analyses.
The pulsed-wave Doppler-derived transmitral ﬂow proﬁle,
pulmonary venous ﬂow proﬁle, and digital color tissue
Doppler-derived mitral annular velocity were obtained from
the apical 4-chamber view. The mitral ﬂow early diastolic wave
velocity (E), late diastolic atrial contraction wave velocity (A),
and the E-wave deceleration time (E-DcT) were measured; the
pulsed wave Doppler-derived pulmonary venous systolic wave
velocity (PV-S), early diastolic wave velocity (PV-D), atrial
contraction reverse wave velocity (PV-Ar), and the D-wave
deceleration time (PV D-DcT), will also be measured; spectral
pulsed-wave tissue Doppler-derived peak systolic velocity (s0),
early diastolic velocity (e0), late diastolic velocity (a0), and the
E/e0 ratio were calculated to estimate the LV ﬁlling pressure
for all patients.
2.2. Statistical analysis
Categorical data were expressed as number (%). Continuous
data were expressed as mean ± SD and were compared using
Student t-test. Correlations were checked for echocardio-
graphic parameters against vitamin D level using Person cor-
relation coefﬁcient. With the exclusion of parameters that
show co-linearity, multivariate regression analysis was done
to check for the best independent predictor of vitamin D
level. The ability of different echocardiographic parameters
to detect vitamin D level <20 ng/ml was done using receiver
operator characteristics curve (ROC-curve), by which the best
cutoff value for prediction that shows best sensitivity and
speciﬁcity was checked. Binominal logistic regression was
done to check the hazard ratios in case of Vitamin D
<20 ng/ml. P-value <0.05 was considered statistically signiﬁ-
cant. All the analyses were performed with commercially
available software (SPSS version 21.0, SPSS, Inc., Chicago,
IL, USA).3. Results
The study included 60 patients admitted to our hospital
for management of symptomatic heart failure with systolic
dysfunction.
Table 2 Echocardiographic measurements among the study
population.
Echocardiographic parameters N= (60)
Mean e0 (cm/s) 6.14 ± 1.81
Mean a0 (cm/s) 7.2 ± 2.6
Mean s0 (cm/s) 5.17 ± 1.4
E (cm/s) 82.7 ± 23
A (cm/s) 64 ± 28
E-DcT 159 ± 76.7
LAV (ml) 77.5 ± 23
EDV (ml) 169 ± 51.1
ESV (ml) 111.2 ± 41.8
EF (%) 34.8 ± 7.9
EDD (mm) 57.5 ± 6.8
ESD (mm) 48.2 ± 7.1
IVRT (ms) 106.8 ± 21.7
IVS thickness (mm) 11.6 ± 3.2
PW thickness (mm) 12 ± 3.2
Mean cardiac wall thickness (mm) 11.8 ± 3.18
LV mass (g) 339 ± 173
E/A 1.65 ± 1
E/e0 14.7 ± 6.6
e0/a0 0.96 ± 0.41
LAV= left atrial volume, EDV= end diastolic volume,
ESV = end systolic volume, EF = ejection fraction, EDD= end
diastolic dimension, ESD= end systolic dimension, IVRT= iso-
volumetric relaxation time, IVS = interventricular septum,
PW= posterior wall.
Table 3 Vitamin D and BNP levels.
All
(n= 60)
Vit.
D <20 ng/ml
(n= 42)
Vit. DP20
ng/ml
(n= 18)
p-value
Vitamin D (ng/ml) 18.9 ± 8.3 14.6 ± 3.9 27.5 ± 6.9 <0.001
BNP (lg/ml) 21.8 ± 8.8 21.6 ± 9.2 22.2 ± 8.1 0.840
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The mean age was 58.5 ± 7.7 years, and 9 patients (15%) were
females. All patients were in sinus rhythm. 22(37%) patients
were diabetics, 26(43%) were hypertensive, 40(67%) were smo-
kers, and (8%) were hyperlipidemic (Table 1).
3.2. Echocardiographic measurements
Table 2 shows the mean values of all echocardiographic diasto-
lic and systolic parameters. Tissue Doppler imaging derived
values were measured from septal and lateral mitral annular
positions and averaged. The average e0 velocity was
6.14 ± 1.81 cm/s, the average a0 velocity was 7.2 ± 2.6 cm/s,
and the average s0 velocity was 5.17 ± 1.4 cm/s. Mitral ﬂow
E wave velocity was 82.7 ± 23 cm/s, A wave velocity
was 64 ± 28 cm/s, and E-wave deceleration time (E-DcT)
was 159 ± 76.7 ms (ms). Left atrial volume (LAV) was
77.5 ± 23 ml, left ventricular end diastolic volume (EDV)
was 169 ± 51.1 ml, left ventricular end systolic volume
(ESV) was 111.2 ± 41.8 ml, and left ventricular ejection frac-
tion (EF) was 34.8 ± 7.9%. Isovolumic relaxation time was
106.8 ± 21.7 ms. The interventricular septal (IVS) thickness
was 11.6 ± 3.2 mm, left ventricular posterior wall (PW) thick-
ness was 12 ± 3.2 mm, and mean LV wall thickness was
11.8 ± 3.18 mm. In addition, the mean left ventricular mass
was 339 ± 173 g. The ratios E/A, E/e0 and e0/a0 were
1.65 ± 1, 14.7 ± 6.6, and 0.96 ± 0.41, respectively (Table 2).
3.3. Vitamin D and BNP levels in the study group
Overall, the mean vitamin D level was 18.9 ± 8.3 ng/ml. 42
(70%) patients had their vitamin D levels below 20 ng/ml (con-
sidered deﬁcient) and 18 (30%) had Vitamin D levels P20 ng/
ml (considered within normal range).
The mean BNP level in our study was 21.8 ± 8.8 lg/ml.
There was no signiﬁcant difference between BNP levels in
patients with vitaminD<20 ng/ml versus patients with vitamin
DP20 ng/ml (21.6 ± 9.2 vs. 22.2 ± 8.1, p= 0.840) (Table 3).
3.4. Comparisons between echocardiographic determinants of
diastolic and systolic functions according to vitamin D levels
It was found that, compared to patients with vitamin D
P20 ng/ml, patients with vitamin D level <20 ng/ml had sig-
niﬁcantly higher average e0 (5.4 ± 1.7 vs. 6.3 ± 1.8 cm/s,Table 1 Basic demographic data.
N= (60)
Age (years) 58.5 ± 7.7
Sex (m/f), n(%) 51(85%)/9(15%)
Cardiac risk factors n(%)
DM 22(37%)
HTN 31(52%)
Sm 46(77%)
HLP 5(8%)
DM= diabetes mellitus, HTN= hypertension, Sm = smoker,
HLP = hyperlipidemic.p= 0.033), signiﬁcantly shorter IVRT (116.7 ± 18 vs.
100.5 ± 22.1 ms, p= 0.011), and signiﬁcantly lower E/e0
(18.5 ± 8.4 vs. 12.5 ± 4.17, p= 0.002). This is suggestive of
a better diastolic function. There was no signiﬁcant difference
between both groups regarding average a0, E wave velocity, A
wave velocity, E-DcT, LAV, E/A, and e0/a0.
It was found that, compared to patients with vitamin D
P20 ng/ml, patients with vitaminD level<20 ng/ml had higher
ESV (96 ± 20 vs. 119.6 ± 49.2 ml, p= 0.05), larger ESD
(45.3 ± 5.1 vs. 49.5 ± 7.5 mm, p= 0.056), higher IVS thick-
ness (9.3 ± 1.7 vs. 12.7 ± 3.2 mm, p< 0.001), higher PW
thickness (9.3 ± 1.9 vs. 13.3 ± 3 mm, p< 0.001), higher mean
LV wall thickness (9.3 ± 1.8 vs. 13 ± 3 mm, p< 0.001), and
higher LV mass (268 ± 79 vs. 372 ± 195 g, p= 0.05), while
average s0, EDV, and EF were not different (Table 4).
3.5. Correlations between echocardiographic determinants of
diastolic and systolic functions versus vitamin D and BNP levels
Regarding the diastolic function, It was found that there was a
signiﬁcant negative correlation between vitamin D and average
Table 5 Correlations with echocardiographic determinants of
LV diastolic and systolic functions versus vitamin D and BNP.
R P
Diastolic function
Mean e0 (cm/s) 0.554 <0.001
Mean a0 (cm/s) 0.112 0.450
E (cm/s) 0.081 0.582
A (cm/s) 0.148 0.322
E-DcT (ms) 0.106 0.474
LAV (ml) 0.104 0.481
IVRT (ms) 0.55 <0.001
E/A 0.158 0.290
E/e0 0.63 <0.001
e0/a0 0.239 0.06
Systolic function
Mean s0 (cm/s) 0.43 <0.001
ESV (ml) 0.41 0.001
EF (%) 0.258 0.044
ESD (mm) 0.41 0.005
IVS thickness (mm) 0.615 <0.001
PW thickness (mm) 0.749 <0.001
Mean thickness (mm) 0.704 <0.001
LV mass (g) 0.54 <0.001
BNP (lg/ml) 0.115 0.386
BNP (lg/ml) Vit D <20 ng/ml
(n= 42)
Vit D P20 ng/ml
(n= 18)
P value = 0.997 P value = 0.035
Table 6 Multivariate analysis for correlation with vitamin D
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relation between vitamin D and both IVRT (r= 0.55,
p< 0.001) and E/e0 (r= 0.63, p< 0.001). The ratio e0/a0 only
showed a trend toward a weak positive correlation (r= 0.239,
p= 0.06), while other parameters of diastolic function did not
show any correlation with vitamin D levels (Table 5).
Regarding the systolic function, it was found that there was
a signiﬁcant negative correlation between vitamin D and all
parameters of systolic function. Vitamin D level correlated
negatively with average s0 velocity (r= 0.43, p< 0.001),
ESV (r= 0.41, p= 0.001), and ESD (r= 0.41, p= 0.005),
while there was a signiﬁcant positive correlation with EF
(r= 0.258, p= 0.044). Signiﬁcant negative correlation was
also noticed for IVS thickness (r= 0.615, p< 0.001,
Table 7), PW thickness (r= 0.749, p< 0.001), mean wall
thickness (r= 0.704, p< 0.001), and LV mass (r= 0.54,
p< 0.001).
Despite that Vitamin D did not show correlation with BNP
overall, patients with vitamin D P20 ng/ml showed a signiﬁ-
cant positive correlation with BNP levels, similar to those
noticed for diastolic function parameters, while this cor-
relation was not found in patients with BNP levels <20 ng/ml.
3.6. Echocardiographic independent predictors of vitamin D
With the exclusion of parameters with expected co-linearity (e0
vs. E/e0, ESD vs. ESV and EF, and IVS, PW, and LV mass vs.
mean wall thickness), a multivariate linear regression model
(Table 6) was initiated for average E/e0, IVRT, average s0,
ESV, and mean LV wall thickness. It was found that E/e0,
IVRT, ESV, and mean LV wall thickness were independent
predictors of vitamin D, (beta = 0.439, 0.243, 0.305,Table 4 Comparisons between echocardiographic determi-
nants of LV diastolic and systolic functions according to
vitamin D level.
Vit. DP20
(n= 18)
Vit. D <20
(n= 42)
p-value
Diastolic function
Mean e0 (cm/s) 5.4 ± 1.7 6.3 ± 1.8 0.033
Mean a0 (cm/s) 6.8 ± 2.6 7.53 ± 2.6 0.355
E (cm/s) 89.3 ± 24 77.7 ± 21.4 0.09
A (cm/s) 59.6 ± 27.4 67.6 ± 29.3 0.361
E-DcT (ms) 151.7 ± 67 164.8 ± 83.8 0.574
LAV (ml) 75.7 ± 18.1 79 ± 26 0.643
IVRT (ms) 116.7 ± 18 100.5 ± 22.1 0.011
E/A 1.85 ± 1.1 1.47 ± 0.92 0.213
E/e0 18.5 ± 8.4 12.5 ± 4.17 0.002
e0/a0 0.89 ± 0.34 0.97 ± 0.41 0.504
Systolic function
Mean s0 (cm/s) 4.78 ± 1.45 5.4 ± 1.33 0.127
EDV (ml) 150.2 ± 28.4 178.8 ± 58 0.058
ESV (ml) 96 ± 20 119.6 ± 49.2 0.05
EF (%) 35.8 ± 7.2 34.2 ± 8.5 0.492
ESD (mm) 45.3 ± 5.1 49.5 ± 7.5 0.056
IVS thickness (mm) 9.3 ± 1.7 12.7 ± 3.2 <0.001
PW thickness (mm) 9.3 ± 1.9 13.3 ± 3 <0.001
Mean thickness
(mm)
9.3 ± 1.8 13 ± 3 <0.001
LV mass (g) 268 ± 79 372 ± 195 0.05
level.
Variable Beta N= 60, adjusted r2 = 0.879
p-value 95% CI
E/e0 .439 .000 .361 .675
IVRT (ms) .243 .001 .040 .136
s0 (cm/s) .022 .772 1.008 .754
ESV (ml) .305 .000 .081 .034
Mean wall thickness (mm) .461 .000 1.484 .8160.461 p< 0.001 = 0.001, <0.001, <0.001, respectively),
while IVRT and average s0 lost correlation.
Next, ROC-curve (Table 7, Fig. 1) was initiated to check
the ability of these variables to detect vitamin D less than
20 ng/ml and it was found that E/e0 and mean wall thickness
could do so with the best area under the curve (AUC),
and accuracy (AUC: 0.752, 0.870, cutoff values: 14.4,
11 mm, sensitivities: 73, 80%, speciﬁcities: 69, 78%, accuracies:
71, 79%).
4. Discussion
The study demonstrated that in patients with heart failure with
systolic dysfunction, vitamin D deﬁciency was associated with
worse LV systolic function and was not related to LV diastolic
function, while, in patients who had relatively normal vitamin
D, higher vitamin D levels were associated with worse LV dia-
stolic function, and was not related to LV systolic function.
Table 7 ROC-curve for detection of vitamin D level <20 ng/
ml.
AUC Cutoﬀ
value
Sensitivity
%
Speciﬁcity
%
Accuracy
%
E/e0 0.752 14.4 73 69 71
IVRT (ms) 0.696 105 67 59 63
s0 (cm/s) 0.743 5.3 73 50 61
ESV (ml) 0.616 103 73 53 63
Mean wall
thickness (mm)
0.870 11 80 78 79
Figure 1 ROC-curve for predictors of Vitamin D <20 ng/ml.
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functions
In this study, generally, vitamin D was negatively associated
with all echocardiographic measures of LV systolic function.
This was proven when we found that ESV, ESD, average s0
were all correlating negatively with serum vitamin D levels.
Moreover, vitamin D was also negatively associated with the
increase of LV wall thickness as well as LV mass. It seems that
the deﬁciency of vitamin D (vitamin D < 20 ng/ml) weakens
its protective effects of vitamin D against ﬁbrosis, myocardial
ﬁber thickening and anti-apoptosis, resulting in wall thicken-
ing and eventually dilatation. The effect, however, was not
noticed as clear in patients with normal vitamin D levels (vita-
min D P20 ng/ml), in whom, the level of vitamin D seemed
not related to the size, thickness or mass of the LV. In contrast,
the general effect noticed in our study was that, surprisingly,
higher vitamin D levels were associated with worse LV diasto-
lic function. This was especially noticed when we found that
higher vitamin D levels were associated with lower average
myocardial early diastolic tissue velocity (e0), higher E/e0 ratio,
and longer IVRT, which are all linked to worse diastolic func-
tions and high left ventricular ﬁlling pressures. Breaking up the
results according to vitamin D levels revealed effects that were
opposite to those of vitamin D on systolic function. All thevariables of diastolic function lost correlation with vitamin
D in patients with vitamin D deﬁciency, while they kept posi-
tive correlations in patients with normal vitamin D level.
4.2. BNP, vitamin D and cardiac function
In our study, all patients, irrespective of their vitamin D level,
had relatively high BNP values. The mean values were not dif-
ferent between patients with vitamin D< orP20 ng/ml.
However, interestingly, the patterns of correlations of vitamin
D with diastolic variables were seen in a relatively similar way
with BNP. If the site of secretion of BNP is taken into account,
one can deduce that the correlation of BNP with vitamin D in
these patients is reasonable, giving the feeling that systolic
heart failure with relatively higher vitamin D levels might be
connected to worse diastolic functions and thus might be
related to higher left atrial pressures and thus higher BNP in
this group of patients. Relations between vitamin D, diastolic
function, left atrial pressure, and BNP however, were lost in
patients with vitamin D deﬁciency. In that case, according to
our results, all these relations seem to be of more association
with systolic function.
4.3. Possible mechanisms
Literature data suggest that a biphasic dose–response curve
exists for vitamin D, with adverse effects associated with very
high and very low vitamin D levels.6,7 Vitamin D deﬁciency
has been observed to induce myocardial hypertrophy and
extracellular matrix production and deposition in myocardial
tissue. Mediated by matrix metalloproteinase, extracellular
matrix remodelling may be involved in progressive LV remod-
elling, dilatation, and heart failure. At the molecular level,
vitamin D also has intriguing immunoregulatory and DNA-
protective properties. Negative effects associated with vitamin
D excess include hyperphosphatemia, hypercalcaemia,
increased matrix metalloproteinase (MMP) levels, medial cal-
ciﬁcation and arterial stiffness. The previous ﬁndings, if true
for endogenous serum vitamin D levels, might also explain
the systolic dysfunction in patients with low vitamin D, and
the diastolic dysfunction in patients with relatively higher vita-
min D, noticed in our study.
4.4. Comparison with previous studies
Our ﬁndings are consistent with previous cross-sectional stud-
ies showing vitamin D deﬁciency associated with worse LV
function.8,9 Another cross sectional study also found that
patients with 25-OH D< 25 nmol/L had larger end-systolic
diameters and reduced fractional shortening, compared with
heart failure patients with 25-OH DP 25 nmol/L, an observa-
tion that is also consistent with our cross-sectional analyses.10
Further, in patients with coronary calciﬁcations, lower vitamin
D levels were found to be associated with higher LV relative
wall thickness11 and the ﬁndings were also supported by
another study of patients on haemodialysis.12 Moreover, three
studies recently showed an association of low vitamin D levels
with shorter survival and increased re-hospitalization rates in
heart failure patients.13,14 Opposite ﬁndings were found in
other studies, including a study of 648 elderly individuals
where serum levels of 25-OH D were reported as not being
304 M.A. Abdel Rahman et al.signiﬁcantly associated with measures of LV geometry or func-
tion.15 Similar results were found at 8-year follow-up.16
Another study not supporting a causal relationship of vitamin
D to heart function and geometry was a double-blinded pla-
cebo controlled 48 week therapy clinical trial with paricalcitol
in 227 patients with chronic kidney disease. The therapy did
not alter LV mass index or improve measures of diastolic
dysfunction.17
In our study, however, there was an important difference in
results than most of the previous studies done on the effect of
vitamin D on LV systolic function that was the loss of such an
effect in patients with normal vitamin D levels. The studies
investigating the effects of vitamin D on LV diastolic functions
are controversial and mostly are not suggestive of possible
relation.15,16,18
5. Conclusion
Our study suggests that vitamin D exerts biphasic effect on
cardiac function according to its serum levels. Reduced vita-
min D (<20 ng/ml) appears to be associated with worse left
ventricular thickness and mass which seems to be linked even-
tually to worse systolic functions in terms of end systolic vol-
ume and end systolic dimension. Higher vitamin D levels
(P20 ng/ml), however, seem to be linked to worse LV diastolic
functions in terms of lower e0, higher E/e0 and longer IVRT.
5.1. Recommendations
Vitamin D levels should be monitored in patients with systolic
dysfunction. Supplementation for reduced vitamin D might be
of beneﬁt in prevention of the increased LV mass and the sub-
sequent worsening in systolic function. Vitamin D supple-
mentations in patients with normal vitamin D levels might
be avoided for the possible effect on diastolic functions in an
already failing heart.
6. Limitations
6.1. Unfortunately, the study suffered the following limitations
This study has small sample size with smaller subgroup num-
bers. Further studies should include larger number of patients
in each subgroup to check whether the ﬁndings of our results
can be reproduced. A study at the molecular and laboratory
level to elaborate the mechanisms noticed for vitamin D effects
was not carried out; thus, further studies should address this
issue. The study did not address the effect of vitamin D on
patients without systolic dysfunction (i.e. heart failure without
systolic dysfunction) and future studies should recruit these
patients and compare them with heart failure patients due to
systolic dysfunction. Finally, our study did not include the
effects of vitamin D in healthy controls. Further studies should
also address this issue.7. Summary
Vitamin D insufﬁciency is linked to many diseases such as
osteoporosis, diabetes, dyslipidemia, cardiovascular, autoim-
mune, cancers, infections and increased mortality. Vitamin Dinsufﬁciency has been deﬁned as a 25(OH) D concentration
of 50–75 nmol/L (20–30 ng/mL), deﬁciency below 20 ng/mL
(50 nmol/L), and severe deﬁciency below 10 ng/mL (25 nmol/
L).
This prospective study was carried out at department of
cardiology Ain Shams University from Nov. 2013 to Sep.
2014. The aim of our study was to study the relation between
serum 25-hydroxy vit. D levels and parameters of cardiac sys-
tolic and diastolic functions in patients with LV systolic heart
failure. The study included 60 patients admitted to our hospi-
tal for management of symptomatic heart failure with systolic
dysfunction. The mean age was 58.5 ± 7.7 years, and 9
patients (15%) were females. All patients were in sinus rhythm.
Patients were admitted with a New York heart association
(NYHA) functional class of 2.48 ± 0.6. 22 (37%) patients
were diabetics, 26 (43%) were hypertensive, 40 (67%) were
smokers, and (8%) were hyperlipidemic. Overall, the mean
vitamin D level was 18.9 ± 8.3 microgram per deciliter (ng/
ml). 42 (70%) patients had their vitamin D levels below
20 ng/ml (considered deﬁcient) and 18 (30%) had Vitamin D
levels P20 ng/ml (considered within normal range).
It was found that, compared to patients with vitamin D
P20 ng/ml, patients with vitamin D level <20 ng/ml had sig-
niﬁcantly higher average e0 (5.4 ± 1.7 vs. 6.3 ± 1.8 cm/s,
p= 0.033), signiﬁcantly shorter IVRT (116.7 ± 18 vs.
100.5 ± 22.1 ms, p= 0.011), and signiﬁcantly lower E/e0
(18.5 ± 8.4 vs. 18.5 ± 8.4, p= 0.002), which is suggestive of
a better diastolic function. There was no signiﬁcant difference
between both groups regarding average a0, E wave velocity, A
wave velocity, E-DcT, LAV, E/A, and e0/a0. Also, It was found
that, compared to patients with vitamin DP20 ng/ml, patients
with vitamin D level <20 ng/ml had higher ESV (119.6 ± 49.2
vs. 119.6 ± 49.2 ml, p= 0.05), larger ESD (45.3 ± 5.1 vs.
49.5 ± 7.5 mm, p= 0.056,), higher IVS thickness (9.3 ± 1.7
vs. 12.7 ± 3.2 mm, p< 0.001), higher PW thickness (9.3 ±
1.9 vs. 13.3 ± 3 mm, p< 0.001), higher mean LV wall thick-
ness (9.3 ± 1.8 vs. 13 ± 3 mm, p< 0.001), and higher LV
mass (268 ± 79 vs. 372 ± 195 g, p= 0.05), while average s0,
EDV, and EF were not different. Our study demonstrated that
in patients with heart failure with systolic dysfunction, vitamin
D deﬁciency was associated with worse LV systolic function
and was not related to LV diastolic functions, while, in
patients who had relatively normal vitamin D, higher vitamin
D levels were associated with worse LV diastolic functions,
and were not related to LV systolic functions.
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